• Зарегестрируйтесь что бы увидеть контакты услуг и продавцов ПАВ

    You need to register to see contacts RC sellers and services.

U.S. Congress Presented Grant Document for Trial of Psychedelics in the Therapy of War Veterans


Well-known member
Reputation +/-
Reaction score
A bill was presented to the US Federal Congress proposing a system of grants to fund private trials and experiments related to the use of psilocybin and other psychedelic substances in the treatment of war veterans, as well as those still in active service. The bill, sponsored by Republican MP Dan Crenshaw, is called the "Douglas Day Bill to Trial Experimental Psychoactive Drugs in the Therapeutics of the Military" in honor of a US Navy SEAL veteran who suffered from PTSD and died a few weeks before the bill was formally presented to the public.

The bill, which already has 11 bipartisan supporters, is proposing $75 million to fund a scientist grant program that can offer programs to study and test the therapeutic efficacy of substances such as psilocybin, psilocin, ibogaine, MDMA, and 5-MeO-DMT. As expected, the trial design should contain a complete research program with all the necessary steps, from preliminary to clinical tests.
Also, projects are required to focus on studying the therapeutic efficacy of these substances in the treatment of "veteran" ailments, in particular, PTSD, brain damage and injuries, as well as depressive and stress disorders.

Grants will be managed by a special committee of experts under the government, headed by the Minister of Defense. Presumably, the projects will initially receive a grant of $15 million for a separate project. Directly to receive grants, once a year, in the period from 2024 to 2028, a committee of experts will select the most practical proposals from incoming proposals.

Any kind of organization will be able to receive funds, from a team of scientists at hospitals and federal laboratories, to private companies and public charitable foundations. If awarded a grant, recipient organizations will be required to submit test success reports every 180 days that have elapsed from the date of approval of disbursement of funds to continue the project and receive additional funding.

Legislation should encourage research into the use of life-saving medicines, namely active and former military personnel, ”said one of the supporters of its adoption, Henry Berkowitz, director of the Veterans for Innovative Treatments NGO about the project. "Medications like these could be the key to successfully treating PTSD and other stress disorders that are causing us to lose up to 20 veterans a day."
  • Like 1
Top Bottom